After BDS debacle, NEET 1st round revised list out
In this allocation, 4,232 MBBS seats and 931 BDS seats were distributed.
The announcement followed DME's earlier decision to remove 100 BDS seats from the counselling process. This reduction occurred after the Union health ministry instructed against student admissions at Guru Govind Singh College of Dental Science and Research Centre, Burhanpur for the 2025-26 academic session.
The timing of the ministry's directive - issued four days before counselling but apparently not acted upon until after allotments were made - had sparked criticism.
Out of the top 300 MP State Quota rankers, around 130 were allotted this college. It's the most preferred institution, chosen by nearly 43% of top candidates. Around 90 top rankers opted for
GMC Bhopal
, making it the second most preferred college - chosen by 30% of the top 300.
The updated allocation results are now accessible on dme.mponline.gov.in. Students with highest rankings received placements at renowned institutions including
Mahatma Gandhi Memorial Medical College
, Indore, and GMC, Bhopal.
Overall MBBS seat selection remained unchanged, with only minor reallocations in private colleges. In BDS, seats were redistributed with slight increases at Mansarovar Dental College, while the total stayed constant.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
8 hours ago
- Time of India
Bengaluru MP asks Union finance minister to exempt import duty on cancer drugs
Bengaluru: Bengaluru Rural MP Dr CN Manjunath met Union finance minister Nirmala Sitharaman Wednesday and urged her to exempt import duty on cancer drugs and equipment to make treatment more affordable. Tired of too many ads? go ad free now His appeal focused on immunotherapy drugs and radiotherapy equipment, which, unlike chemotherapy drugs, are not covered under existing exemptions. "The minister responded positively and promised to examine the request on priority," Manjunath said Thursday. He said the cost of immunotherapy ranges between Rs 20-50 lakh per patient for each treatment cycle, placing it out of reach for many, particularly those from weaker economic backgrounds. Since most of these drugs and machines are imported, lack of exemption significantly adds to treatment costs, he said. Stressing that immunotherapy and radiotherapy are often used alongside chemotherapy and form the core of advanced cancer care, Manjunath said extending exemptions is crucial, given the rising number of cancer cases in India. "At present, customs duty has been waived on most chemotherapy drugs. But immunotherapy and radiotherapy, which are equally critical, remain excluded," he pointed out.
The Hindu
13 hours ago
- The Hindu
Ministers, MPs from Karnataka meet Shivraj Singh Chouhan over issues faced by arecanut growers
Ministers and Lok Sabha members from Karnataka held a meeting with Union Minister for Agriculture and Farmers' Welfare Shivraj Singh Chouhan in Delhi on Thursday, and discussed the issues faced by arecanut growers in the State and Kerala. They demanded funds for research on arecanut diseases and strict measures to stop the illegal import of areca and pepper. Union Minister for Steel H.D. Kumaraswamy; Union Minister for Consumer Affairs Pralhad Joshi; Minister of State for Railways V. Somanna; Lok Sabha members B.Y. Raghavendra, Vishweshar Hegde Kageri, Govind Karjol, Capt. Brijesh Chowta, Srinivasa Poojary, Prabha Mallikarjun; former minister Araga Jnanendra; CAMCP president Kishor Kodgi; and others attended the meeting. Memorandum Mr. Raghavendra, in a memorandum submitted to Mr. Chouhan, appealed to him to finalise the official report on evidence-based research on arecanut and human health, and make it public at the earliest. Mr. Raghavendra said that finalising the report and making it public were critical to substantiate the scientific and medicinal aspects of arecanut. This is significant in the backdrop of the World Health Organisation classifying arecanut as carcinogenic, and the case on the issue is pending before the Supreme Court. He urged the Union Minister to allocate funds for research on Yellow-Leaf-Disease (YLD) and other diseases affecting arecanut in parts of Dakshina Kannada, Kodagu, Shivamogga, and Chikkamagaluru in Karnataka and parts of Kerala. 'Farmers are experiencing severe loss and distress due to these diseases,' Mr. Raghavendra said. The Lok Sabha member requested the Union Minister to implement strict measures for curbing illegal import of arecanut and pepper via the Myanmar border area. He appealed to the Minister to strengthen crop insurance facilities for the benefit of growers. 'A modern, technology-based framework involving both Central and State governments should be developed for accurate measurement of rainfall, climatic disruptions, and disease outbreaks,' Mr. Raghavendra stated.
The Hindu
13 hours ago
- The Hindu
Report recommends restoring State autonomy in health and medical education for better outcomes
A report by Ezhilan Naganathan, MLA, Thousand Lights Constituency, Chennai, and part-time member of State Planning Commission, has highlighted the increasing centralisation of the health and medical education sectors and has called for restoring constitutional and operational State autonomy. According to the report, submitted to the High-Level Committee on Union-State Relations, set up by the government of Tamil Nadu, there are six key areas where the Union government has encroached upon the State's functioning, overriding State-specific needs and State-specific delivery of healthcare. The first is medical education, originally in the State List and then brought to the Concurrent List. This arrangement, where the Union government frames policy for healthcare and medical education while the State delivers the healthcare services, creates a policy-implementation gap, it says. The report recommends restoring medical education to the State List and allowing States to be the sole authority for public health and medical education. The second area is replacing the Medical Council of India (MCI) with the National Medical Commission (NMC), a move that, the report argues, limited the States' role in framing curricula and guidelines. It also flags concerns with NEET and NEXT (exams for admission to medical college and for licensing practice), pointing out that NEET heavily favours the CBSE/NCERT syllabus and that it has led to a massive coaching class industry, not to mention leading to a decrease in government school students being able to secure admission. It recommends abolishing the NMC, bringing back the MCI, and allowing States to decide on admission procedures and examination systems. One other area the report deals with is organ transplantation programmes: it notes that recent moves by the Union government to centralise organ allocation and data management through the National Organ and Tissue Transplant Organisation (NOTTO) 'have raised serious concerns about efficiency, fairness, and federal balance,' especially as Tamil Nadu has been a pioneer in this field. The report, among other things, recommends a dual-tier system, with State-led allocation for intra-State matches, and NOTTO's role limited to inter-State sharing when no State recipient is available; and ensuring Central rules cannot override State policies that protect socioeconomically disadvantaged patients. The report also examines the centralisation of drug regulation, focusing on the role of the Central Drug Standard Control Organisation and its impact on States; the operational model of Centre-funded health schemes, which often come with conditions; the imposition of uniform parameters that fail to reflect State-specific health priorities; and what it terms 'cultural centralisation'. According to the report, this refers to the standardisation of health communication, public campaigns, and even medical curricula 'in ways that undermine linguistic plurality, regional identity, and locally evolved practices.' The report points out that centralisation 'risks flattening diversity into inefficiency' and urges that States be empowered financially and institutionally for better health systems.
